UBS Lux Equity Fund Biotech USD vs Landkreditt Utbytte
1. UBS Lux Equity Fund Biotech USD
2. Landkreditt Utbytte
-
Security
Landkreditt Utbytte A
-
Fee
1.29%
-
ISIN
NO0010662836
-
Holdings
25
Fund Holdings
We have information about 11 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Moderna (9.21) and Vertex (8.44). In comparison with Landkreditt Utbytte, we have 14 holdings where is the largest holding (7.43), followed by (5.98) and (5.18).
All Holdings
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and Landkreditt Utbytte.
UBS Lux Equity Fund Biotech USD |
Landkreditt Utbytte |
1. Regeneron Pharmaceuticals Inc 10.04 % |
1. 7.43 % |
2. Moderna Inc 9.21 % |
2. 5.98 % |
3. Vertex Pharmaceuticals Inc 8.44 % |
3. 5.18 % |
4. Alnylam Pharmaceuticals Inc 8.08 % |
4. 5.08 % |
5. AbbVie Inc  4.91 % |
5. 5.06 % |
6. Gilead Sciences Inc  4.66 % |
6. 4.31 % |
7. Amgen Inc  4.43 % |
7. 3.84 % |
8. BioNTech SE 4.13 % |
8. 3.63 % |
9. Karuna Therapeutics Inc 3.75 % |
9. 3.59 % |
- |
10. 3.58 % |
- |
11. 3.48 % |
- |
12. 3.47 % |
- |
13. 3.02 % |
- |
14. 2.93 % |
- |
15. 2.88 % |
- |
16. 2.81 % |
- |
17. 2.8 % |
- |
18. 2.74 % |
- |
19. 2.74 % |
- |
20. 2.58 % |
- |
21. 2.52 % |
- |
22. 2.37 % |
- |
23. 2.33 % |
- |
24. 2.1 % |
- |
25. 1.94 % |
The list of fund holdings was last updated on July 25, 2025.